Kurt Leibundgut
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 18
- Acute Myeloid Leukemia Research 7
- Clinical Biochemistry top 2%
- Oncology top 5%
- Neutropenia and Cancer Infections 18
- Genetics top 5%
- Blood disorders and treatments 7
- Emergency Medicine top 5%
- Hematological disorders and diagnostics 9
-
- Childhood Cancer Survivors' Quality of Life 17
-
- Acute Lymphoblastic Leukemia research 13
-
- Neuroblastoma Research and Treatments 7
- Co-authors
- Andreas HirtRoland A. AmmannFelix NiggliChristoph AebiA LüthyBehrouz Mansouri TaleghaniJ. PlaschkesNicole Bodmer
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Kurt Leibundgut
92 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 107
- Hematology 332
- Clinical Biochemistry 163
- Oncology 469
- Genetics 176
- Emergency Medicine 118
Countries citing papers authored by Kurt Leibundgut
This map shows the geographic impact of Kurt Leibundgut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Leibundgut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Leibundgut more than expected).
Fields of papers citing papers by Kurt Leibundgut
This network shows the impact of papers produced by Kurt Leibundgut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Leibundgut. The network helps show where Kurt Leibundgut may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kurt Leibundgut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2020 | 11 | |
| 4 | 2018 | 7 | |
| 5 | 2016 | 25 | |
| 6 | 2015 | 15 | |
| 7 | 2015 | 8 | |
| 8 | 2015 | 15 | |
| 9 | 2014 | 28 | |
| 10 | 2014 | 14 | |
| 11 | 2014 | 8 | |
| 12 | 2007 | 9 | |
| 13 | 2001 | 14 | |
| 14 | 1999 | 6 | |
| 15 | 1999 | 32 | |
| 16 | 1997 | 8 | |
| 17 | 1996 | 12 | |
| 18 | 1995 | 53 | |
| 19 | 1995 | 46 | |
| 20 | 1992 | 7 |
About Kurt Leibundgut
Kurt Leibundgut is a scholar working on Hematology, Oncology and Pediatrics, Perinatology and Child Health, having authored 92 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (18 papers), Neutropenia and Cancer Infections (18 papers), Childhood Cancer Survivors' Quality of Life (17 papers), Acute Lymphoblastic Leukemia research (13 papers), Hematological disorders and diagnostics (9 papers), Blood disorders and treatments (7 papers), Acute Myeloid Leukemia Research (7 papers) and Neuroblastoma Research and Treatments (7 papers). The work is most often cited by research in Hematology (332 citations), Clinical Biochemistry (163 citations) and Oncology (469 citations). Kurt Leibundgut has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Andreas Hirt, Roland A. Ammann, Felix Niggli, Christoph Aebi, A Lüthy, Behrouz Mansouri Taleghani, J. Plaschkes, Nicole Bodmer, Stefano Fontana and Maja Steinlin. Their work appears in journals such as Blood, PLoS ONE and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.